NovaBridge Biosciences
NBP
$1.70
-$0.08-4.49%
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.24% | 21.59% | -- | -- | -20.18% |
| Total Receivables | 619.39% | 52.99% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.58% | -38.13% | -- | -- | -94.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 319.74% | -- | -- | -- |
| Total Current Assets | 18.11% | 23.11% | -- | -- | -27.26% |
|
|
|||||
| Total Current Assets | 18.11% | 23.11% | -- | -- | -27.26% |
| Net Property, Plant & Equipment | 65.93% | -22.35% | -- | -- | -13.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 135.60% | 106.01% | -- | -- | 162.72% |
| Total Assets | 12.01% | 22.49% | -- | -- | -18.56% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 71.36% | 123.35% | -- | -- | -42.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 49.59% | 9.19% | -- | -- | 15.74% |
| Total Finance Division Other Current Liabilities | -- | 8,560.38% | -- | -- | -- |
| Total Other Current Liabilities | -- | 8,560.38% | -- | -- | -- |
| Total Current Liabilities | 252.82% | 218.12% | -- | -- | -47.42% |
|
|
|||||
| Total Current Liabilities | 252.82% | 218.12% | -- | -- | -47.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.08% | -29.03% | -- | -- | -18.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 205.14% | 156.78% | -- | -- | -41.99% |
|
|
|||||
| Common Stock & APIC | 5.00% | 4.57% | -- | -- | 0.07% |
| Retained Earnings | -5.83% | -3.60% | -- | -- | -3.04% |
| Treasury Stock & Other | 21.96% | 34.41% | -- | -- | -7.77% |
| Total Common Equity | 2.22% | 14.80% | -- | -- | -16.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.22% | 14.80% | -- | -- | -16.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.22% | 14.80% | -- | -- | -16.86% |
|
|
|||||